Health Highlights: March 28, 2022
Stakes are high ahead of FDA panel vote on ALS drug. Advocacy groups are pressing the agency to fast-track approval of an experimental drug treatment for the deadly neurological disease. But are regulators moving too fast? Read more
Second COVID-19 vaccine boosters to be offered to Americans over 50. Optional second boosters of the Pfizer or Moderna vaccines could be authorized by the U.S. Food and Drug Administration as early as this week. But debate rages over the timing and effectiveness of such a move. Read more
Owners can play big role in dogs' problem behaviors. Nearly 1 in 3 pet dogs suffer from ADHD-like repetitive behaviors, and researchers now suspect that an animal's home life could be the cause. Read more
Hospitalization extremely rare for the vaccinated or those with prior COVID infection. A study of more than 100,000 American patients found their odds of winding up in the hospital following a 'breakthrough' infection was practically nil. Read more
Related Posts
Metachronous Pathology Assessed in Young-Onset CRC Survivors
TUESDAY, Sept. 27, 2022 (HealthDay News) -- The incidence rate of clinically...
ACC: Bempedoic Acid Cuts Cardiovascular Event Risk in Statin-Intolerant
MONDAY, March 6, 2023 (HealthDay News) -- Treatment with bempedoic acid is...
Un estudio no encuentra un vínculo entre el fútbol americano juvenil y problemas del cerebro o conductuales
LUNES, 3 de enero de 2022 (HealthDay News) -- Muchos padres luchan con la...
Greater Adiposity Linked to Worse Outcomes in Patients With HFrEF
WEDNESDAY, March 22, 2023 (HealthDay News) -- For patients with heart failure...